Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapies for treating myelodysplastic syndromes and acute myeloid leukemia

Combination therapies for treating myelodysplastic syndromes and acute myeloid leukemia

US Patent 11795223 · Granted Oct 24, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic antigen binding proteins specific for CD93 and methods of use thereo2025
Dosing parameters for CD47 targeting therapies to hematologic malignancies2025
Dosing parameters for CD47 targeting therapies to hematologic malignancies2025
Methods for achieving therapeutically effective doses of anti-CD47 agents2025
Methods for treating myeloma by achieving therapeutically effective doses of ant2025
Dosing parameters for CD47 targeting therapies to hematologic malignancies2025
Dosing parameters for CD47 targeting therapies to hematologic malignancies2025
Methods for manipulating phagocytosis mediated by CD472024
Methods for manipulating phagocytosis mediated by CD472024
Anti-CD47 agent-based treatment of CD20-positive cancer2024
Anti-CD47 agent-based treatment of CD20-positive cancer2024
High affinity PD-1 agents and methods of use2023